GRIESHABER DELAMINATION SPATULA DSP
Received Mar 17, 2025 · Event occurred Dec 1, 2023
Report 3003398873-2025-00221 · MDR key 21615762
Device
Generic name
Hook, Ophthalmic
Manufacturer
Alcon Grieshaber AgModel number
NACatalog number
337.94
Lot number
ASKU
Product problems
- Adverse Event Without Identified Device or Use Problem
- Adverse Event Without Identified Device or Use Problem
Patient
NA · Male
- Inflammation
- Retinal Hemorrhage
- Inflammation
- Retinal Hemorrhage
Narrative
Description of Event or Problem
ADDITIONAL INFORMATION RECEIVED INDICATED THAT THE INFLAMMATION NOTED.
Additional Manufacturer Narrative
ADDITIONAL INFORMATION WAS PROVIDED IN SECTIONS B.5 AND H.6. THE MANUFACTURER INTERNAL REFERENCE NUMBER IS: (B)(4). H.10 REFLECTS ALL RELATED REPORT NUMBERS ASSOCIATED WITH THIS PRODUCT EVENT THAT HAVE BEEN SUBMITTED AT THIS TIME.
Additional Manufacturer Narrative
ADDITIONAL INFORMATION WAS PROVIDED IN SECTIONS H.6., AND H.11. NO LOT NUMBER WAS IDENTIFIED WITHIN THE SURVEY AND THEREFORE WITHIN THIS COMPLAINT, WHICH IS WHY THE ASSOCIATED MANUFACTURING DOCUMENTATION COULD NOT BE REVIEWED. ALL PRODUCT AND BATCH HISTORY RECORDS ARE QUALITY REVIEWED PRIOR TO PRODUCT RELEASE, ENSURING THAT ALL PRODUCTS ON THE MARKET FULFILL THE RELEVANT REQUIREMENTS. SINCE THE QUESTIONNAIRE RETROSPECTIVELY COLLECTED DATA, NO SAMPLE IS AVAILABLE TO BE PROVIDED TO THE RESPONSIBLE SITE FOR AN IN-DEPTH INVESTIGATION. NOT ENOUGH INFORMATION WAS PROVIDED TO PROPERLY COMPLETE AN INVESTIGATION. THE ROOT CAUSE OF THIS COMPLAINT COULD NOT BE IDENTIFIED. THE EXACT ROOT CAUSE FOR THE CUSTOMER¿S REPORTED EVENT IS UNKNOWN. THEREFORE, NO SPECIFIC ACTION CAN BE TAKEN. AN OVERALL RISK ASSESSMENT WAS PERFORMED AND CONCLUDED THAT NO FURTHER ACTIONS ARE REQUIRED. ADDITIONALLY, COMPLAINTS ARE REVIEWED AND MONITORED AT REGULAR INTERVALS FOR ADVERSE TRENDS. NO ADDITIONAL ACTIONS ARE NEEDED. THE MANUFACTURER INTERNAL REFERENCE NUMBER IS: (B)(4). H.10 REFLECTS ALL RELATED REPORT NUMBERS ASSOCIATED WITH THIS PRODUCT EVENT THAT HAVE BEEN SUBMITTED AT THIS TIME.
Additional Manufacturer Narrative
INVESTIGATION INCLUDING ROOT CAUSE ANALYSIS IS IN PROGRESS. A SUPPLEMENTAL MDR WILL BE FILED AS NECESSARY IN ACCORDANCE WITH 21 CFR 803.56 WHEN ADDITIONAL REPORTABLE INFORMATION BECOMES AVAILABLE. THE MANUFACTURER INTERNAL REFERENCE NUMBER IS: (B)(4). H.10 REFLECTS ALL RELATED REPORT NUMBERS ASSOCIATED WITH THIS PRODUCT EVENT THAT HAVE BEEN SUBMITTED AT THIS TIME.
Description of Event or Problem
A RETROSPECTIVE POST-MARKET CLINICAL FOLLOW-UP STUDY INDICATED THAT THE PATIENT UNDERWENT A VITREO RETINAL PROCEDURE IN THE EYE (UNKNOWN) USING AN OPHTHALMIC SPATULA TO PRESERVE THE CURRENT VISION. DURING SURGERY THE PATIENT EXPERIENCED RETINAL HEMORRHAGE. THE SURGERY WAS COMPLETED ON THE SAME DAY. IT WAS ALSO REPORTED THAT NO TREATMENT WAS PROVIDED. THE CURRENT CONDITION OF THE PATIENT WAS IMPROVING FROM THE REPORTED EVENT, PERIOPERATIVE IATROGENIC HOLES AND INTRAOPERATIVE SUPPLEMENTAL RETINAL LASER. NO FURTHER FOLLOW UP WILL BE CONDUCTED.